MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$145M
Net Income
-$782M
Net Profit Margin
-539.31%
EPS
-$1.97
Unit: Million (M) dollars
Revenue Breakdown
    • Gross product sales
    • Product And Service Other
    • Wholesaler chargebacks, discount...
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
145
389
678
1,016
Cost of sales
93
955
452
207
Research and development
651
649
775
801
Selling, general and administrative
216
173
308
268
Total operating expenses
960
1,777
1,535
1,276
Loss from operations
-815
-1,388
-857
-260
Interest income
67
72
70
73
Other (expense) income, net
-19
-18
-12
0
Loss before income taxes
-767
-1,334
-799
-187
Provision for income taxes
15
9
27
13
Net loss
-782
-1,343
-826
-200
Basic EPS
-1.97
-3.4
-2.107
-0.51
Diluted EPS
-1.97
-3.4
-2.107
-0.51
Basic Average Shares
398,000,000
395,000,000
392,000,000
390,000,000
Diluted Average Shares
398,000,000
395,000,000
392,000,000
390,000,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

MRNA Income Statement Sankey DiagramSankey diagram visualizing MRNA income statement for the periodNet loss-$782M (5.21%↑ Y/Y)Gross product sales$122M (-30.68%↓ Y/Y)Loss before incometaxes-$767M (6.23%↑ Y/Y)Provision for income taxes$15M (114.29%↑ Y/Y)Interest income$67M (-17.28%↓ Y/Y)Product Sales$94M (-17.54%↓ Y/Y)Product And ServiceOther$51M (82.14%↑ Y/Y)Total product salesprovision adjustments$28M (-54.84%↓ Y/Y)Returns, rebates andother fees-$22M Loss from operations-$815M (10.14%↑ Y/Y)Total revenue$145M (2.11%↑ Y/Y)Other (expense)income, net-$19M (-337.50%↓ Y/Y)Wholesaler chargebacks,discounts and fees$50M (-19.35%↓ Y/Y)Total operatingexpenses$960M (-8.48%↓ Y/Y)Research and development$651M (-7.00%↓ Y/Y)Selling, general andadministrative$216M (-6.09%↓ Y/Y)Cost of sales$93M (-21.85%↓ Y/Y)
Master Final R&D Day 2021 Slides (09

Moderna, Inc. (MRNA)

Master Final R&D Day 2021 Slides (09

Moderna, Inc. (MRNA)